A genetically engineered version of a common cold virus appears to kill cancer cells without killing healthy tissue, according to a preliminary study in people with severe, untreatable gastrointestinal cancer that had spread to the liver. Their cancer couldn’t be treated with surgery and no longer responded to currently available drugs.
The researchers injected the engineered virus into the artery leading to the liver.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.